Independent of familial history, germline or somatic mutations in BRCA1 and BRCA2 genes occur in 5–10% [18] of patients with pancreatic cancers, with a prevalence for BRCA2 ranging from 3.6–7% and <3% for BRCA1 [19]. Here, BRCA1 is linked to familial pancreatic carcinoma.